Frailty Linked to Lower Use of Guideline Treatments in HFrEF at AshTip Solution.

As experimental drugs to treat non-alcoholic steatohepatitis (NASH) continue to dash themselves on the shoals of the federal regulatory system, clinicians should know that at least one effective therapy exists. 2023-06-20

Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients, with the tussle over profits now spilling into statehouses across the country. 2023-07-05

Concerns about lower lymphocyte levels in HIV with the once-daily oral drug islatravir in combination with doravirine changed the trajectory of clinical trial plans that are now back on track, according to investigators. 2023-08-04

The World Health Organization (WHO) today released its updated Bacterial Priority Pathogens List (BPPL) 2024, featuring 15 families of antibiotic-resistant bacteria grouped into critical, high and medium categories for prioritization. The list provides guidance on the development of new and necessary treatments to stop the spread of antimicrobial resistance (AMR). 2024-05-18